In the BioHarmony Drug Report Database
Ranitidine
Zantac (ranitidine) is a small molecule pharmaceutical. Ranitidine was first approved as Zantac on 1983-06-09. It is used to treat duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, and zollinger-ellison syndrome in the USA. The pharmaceutical is active against histamine H2 receptor.
Trade Name
|
Zantac |
|---|---|
Common Name
|
ranitidine |
ChEMBL ID
|
CHEMBL1790041 |
Indication
|
duodenal ulcer, gastroesophageal reflux, peptic esophagitis, stomach ulcer, zollinger-ellison syndrome |
Drug Class
|
H2-receptor antagonists (cimetidine type) |
Image (chem structure or protein)